Drug · DIN 02452928
XTORO
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since March 11, 2019.
- Drug Identification Number (DIN)
- 02452928
- Company (DIN owner)
- Merlion Pharmaceuticals GmbhBerlin, Germany
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Otic
- Therapeutic class (ATC)
- Antiinfectives S02AA
- Class
- Human
- Record last updated
- June 19, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FINAFLOXACIN | 0.3 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 11, 2019: NOC 21952New Drug Submission (NDS) · Change in Product Ownership Update to the inner labels, the outer label and the package insert
- March 11, 2016: NOC 17866New Drug Submission (NDS)